Fight against Atherosclerotic Cardiovascular Disease: A Biologics not a Small...
Curator: Aviva Lev-Ari, PhD, RN If Biologics will help increase HDL in wide market penetration, the market share of Statins will be negatively impacted. The biologics was developed by NIH funding, as...
View ArticleCholesteryl Ester Transfer Protein (CETP) Inhibitor: Potential of Anacetrapib...
Curator: Aviva Lev-Ari, PhD, RN On April 3, 2012 we published Fight against Atherosclerotic Cardiovascular Disease: A Biologics not a Small Molecule – Recombinant Human lecithin-cholesterol...
View Article
More Pages to Explore .....